+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Metabolomics - Global Market Trajectory & Analytics

  • ID: 1882093
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • AB SCIEX
  • Bruker Corporation
  • Chenomx, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • Metanomics GmbH
Global Metabolomics Market to Reach $3.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Metabolomics estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 12.8% over the analysis period 2020-2027. Bioanalytical Instruments & Equipment, one of the segments analyzed in the report, is projected to record a 11% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metabolomics Applications segment is readjusted to a revised 14.7% CAGR for the next 7-year period.





The U.S. Market is Estimated at $443.3 Million, While China is Forecast to Grow at 12.4% CAGR

The Metabolomics market in the U.S. is estimated at US$443.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$614.4 Million by the year 2027 trailing a CAGR of 12.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 11.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Bioinformatics Tools in Metabolomic Research Segment to Record 16.6% CAGR

In the global Bioinformatics Tools in Metabolomic Research segment, USA, Canada, Japan, China and Europe will drive the 16.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$95 Million in the year 2020 will reach a projected size of US$275.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$418.5 Million by the year 2027.

Select Competitors (Total 29 Featured):
  • AB SCIEX
  • Agilent Technologies, Inc.
  • Biocrates Life Sciences AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Chenomx, Inc.
  • Human Metabolome Technologies, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • Metanomics GmbH
  • Shimadzu Corporation
  • SiDMAP, LLC
  • Thermo Fischer Scientific Inc.
  • Waters Corporation
Frequently Asked Questions about the Global Market for Metabolomics

What is the estimated value of the Global Market for Metabolomics?

The Global Market for Metabolomics was estimated to be valued at $1.5 Billion in 2020.

What is the growth rate of the Global Market for Metabolomics?

The growth rate of the Global Market for Metabolomics is 12.9%, with an estimated value of $3.5 Billion by 2027.

What is the forecasted size of the Global Market for Metabolomics?

The Global Market for Metabolomics is estimated to be worth $3.5 Billion by 2027.

Who are the key companies in the Global Market for Metabolomics?

Key companies in the Global Market for Metabolomics include AB SCIEX, Agilent Technologies, Inc., Biocrates Life Sciences AG, Bio, Rad Laboratories, Inc., Bruker Corporation, Chenomx, Inc., Human Metabolome Technologies, Inc. and Metabolon, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AB SCIEX
  • Bruker Corporation
  • Chenomx, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • Metanomics GmbH

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Metabolomics - The Current Spotlight of "Omics" Toolbox
  • Application Areas
  • Metabolomics in Cancer Detection
  • Growth Drivers
  • Market Barriers & Challenges
  • Recent Market Activity
  • Metabolomics: A Regional Perspective
  • US and Europe Spearhead the Global Metabolomics Market
  • Asia-Pacific: The Fastest Growing Metabolomics Market
  • Biotechnology and Pharmaceutical Sectors Drive Metabolomics Research
  • Demand for Data Analysis Tools and Software on Rise
  • Bioinformatics-based Metabolomics Applications Poised to Grow
  • List of Select Metabolomic Analysis Software
  • Metabolomics in Forensics and PMI Analysis
  • Metabolomics Research Provides New Tools to Understand Human Health
  • Techniques to Examine Metabolites
  • Understanding Human Health and Predicting Disease Risk
  • Causality Assessment
  • NMR-based Metabolomics Screens Desirable LAB Strain with Specific Fermentation Characteristics
  • NMR-based Metabolomics
  • Metabolomics Laboratory Management Systems (LIMS): Growing in Significance
  • Synopsis of Select Metabolomic Databases
  • Some Examples of Metabolomics LIMS
  • Targeted Metabolomics in Newborn Screening: An Area of Success
  • Lack of Standardization - A Prime Concern
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
  • AB SCIEX (USA)
  • Agilent Technologies, Inc. (USA)
  • Biocrates Life Sciences AG (Austria)
  • Metanomics GmbH (Germany)
  • Bio-Rad Laboratories, Inc. (USA)
  • Bruker Corporation (USA)
  • Chenomx, Inc. (Canada)
  • Human Metabolome Technologies, Inc. (Japan)
  • LECO Corporation (USA)
  • Metabolon, Inc. (USA)
  • Shimadzu Corporation (Japan)
  • SiDMAP, LLC (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Waters Corporation (USA)

3. MARKET TRENDS & DRIVERS
  • High Performance Liquid Chromatography (HPLC) Dominates the Market
  • Major Trends in Gas Chromatography: A Quick Review
  • Advances in GC Technology
  • Hyphenated Technologies: Order of the Day
  • Liquid Chromatography Gains Space in Metabolomics Analysis
  • MS Systems with UHPLC: A Novel Fusion
  • HILIC Systems Soaring in Popularity
  • Capillary Electrophoresis Gains Prominence

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Bioanalytical Instruments & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Bioanalytical Instruments & Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Bioanalytical Instruments & Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Metabolomics Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Metabolomics Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Metabolomics Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Bioinformatics Tools in Metabolomic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Bioinformatics Tools in Metabolomic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Bioinformatics Tools in Metabolomic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 13: USA Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: USA Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: USA 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • CANADA
  • Table 16: Canada Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 17: Canada Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: Canada 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 19: Japan Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: Japan Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: Japan 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • CHINA
  • Table 22: China Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 23: China Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: China 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 25: Europe Current & Future Analysis for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 26: Europe Historic Review for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: Europe 15-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 28: Europe Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: Europe Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: Europe 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 31: France Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: France Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: France 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 34: Germany Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Germany Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Germany 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • ITALY
  • Table 37: Italy Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Italy Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: Italy 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 40: UK Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: UK Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: UK 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 43: Rest of Europe Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Rest of Europe Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Rest of Europe 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 46: Asia-Pacific Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Asia-Pacific Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Asia-Pacific 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 49: Rest of World Current & Future Analysis for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Rest of World Historic Review for Metabolomics by Segment - Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 51: Rest of World 15-Year Perspective for Metabolomics by Segment - Percentage Breakdown of Value Sales for Bioanalytical Instruments & Equipment, Metabolomics Applications and Bioinformatics Tools in Metabolomic Research for the Years 2012, 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 29
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AB SCIEX
  • Agilent Technologies, Inc.
  • Biocrates Life Sciences AG
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Chenomx, Inc.
  • Human Metabolome Technologies, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • Metanomics GmbH
  • Shimadzu Corporation
  • SiDMAP, LLC
  • Thermo Fischer Scientific Inc.
  • Waters Corporation
Note: Product cover images may vary from those shown